LAS100977
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LAS100977, covering 2017-04-10 to 2018-01-26. Get the full timeline:
Most recent: Clinical Trial Update: Single Dose Study to Assess Efficacy, Safety and Tolerability of LAS100977 in Asthmatic Patients. [Phase 2]